NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B
NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of 24 months until 28th February 2021, with options to extend up to a further 24 month.
Buyer
NHS England
Value
£384,000,000
Published
25 Mar 2019
Closes
11 Dec 2018
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
1 Mar 2019
Contract ends
28 Feb 2021
CPV classifications
33141530
Blood coagulants
Lots
Lot default NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B
£192,000,000
NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of 24 months until 28th February 2021, with options to extend up to a further 24 month.
Delivery: British Oversea Territories, Channel Islands, Europe, Guernsey, Isle of Man, Jersey
Documents
Unlock document linkOpportunity notice on Contracts Finder
12 Mar 2019
Opportunity notice on Contracts Finder
Tender notice · Web page
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
Contains public sector information licensed under the Open Government Licence v3.0.